Last update on: 04/09/2009
Children and adolescents with cancer require the best type of therapy possible. This can only be ensured within the framework of high quality trial platforms.
These study platforms guarantee optimal standardised therapies and monitor innovative therapy concepts, optimised concomitant therapies, systematic monitoring, as well as therapy concepts due to insufficient responses.
The integration of research questions into the diagnosis as well as into further therapy processes leads to risk-adapted therapy strategies, and ,thus, to maximum individual benefit for the child concerned.
Cancer illnesses in children require highly complex treatment concepts and innovation, in order to improve the chances of recovery.
„The integration of therapy optimisation and high quality treatment, integrated with research aspects, is clinical research.”
Ruth Ladenstein, MD
Paediatric oncologist at the St. Anna Children’s Hospital and
Head of the department of „Studies and Statistics“ at the St. Anna Children’s Cancer Research Institute
§§§ Eine Interview-Aufzeichnung während einer Pressekonferenz der St. Anna Children's Cancer Research Institute (19. Nov. 2008) finden Sie in unserem Dokumentations-Archiv vor.